Plasma steroid and protein hormone concentrations in patients with benign prostatic hypertrophy and in normal men

1979 ◽  
Vol 35 (6) ◽  
pp. 844-845 ◽  
Author(s):  
E. Ortega ◽  
E. Ruiz ◽  
M. C. Mendoza ◽  
A. Martin-Andres
Keyword(s):  
Benign Prostatic Hypertrophy ◽  
Prostatic Hypertrophy ◽  
Normal Men

Excretion of Three Major Prostatic Secretory Proteins in the Urine of Normal Men and Patients With Benign Prostatic Hypertrophy or Prostate Cancer

1987 ◽  
Vol 138 (6) ◽  
pp. 1482-1483
Author(s):  
J. Tremblay ◽  
G. Frenette ◽  
R.R. Tremblay ◽  
A. Dupont ◽  
M. Thabet ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Benign Prostatic Hypertrophy ◽  
Prostatic Hypertrophy ◽  
Secretory Proteins ◽  
Normal Men

Excretion of three major prostatic secretory proteins in the urine of normal men and patients with benign prostatic hypertrophy or prostate cancer

The Prostate ◽  
1987 ◽  
Vol 10 (3) ◽  
pp. 235-243 ◽  
Author(s):  
Jacques Tremblay ◽  
Gilles Frenette ◽  
Roland R. Tremblay ◽  
André Dupont ◽  
Michel Thabet ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Benign Prostatic Hypertrophy ◽  
Prostatic Hypertrophy ◽  
Secretory Proteins ◽  
Normal Men

Laser treatment of benign prostatic hypertrophy

1996 ◽  
Vol 63 (1) ◽  
pp. 77-80
Author(s):  
S. Guazzieri ◽  
W. Cecchetti ◽  
M. Meneguolo ◽  
G. D'incà ◽  
R. Bertoldin
Keyword(s):  
Laser Treatment ◽  
Benign Prostatic Hypertrophy ◽  
Prostatic Hypertrophy ◽  
Laser Source ◽  
Experimental Procedure ◽  
The Usa ◽  
Side Emission ◽  
Pace Maker ◽  
Stable Laser ◽  
Good Flow

— Laser treatment of benign prostatic hypertrophy (BPH) has gradually become more widespread over the last few years. In the USA it is considered an alternative to endoscopic resection as far as insurance payments are concerned. Different methods are used but the most common and suitable one for urologists is the removal and coagulation of the prostatic tissue under visual control (VLAP or ELAP). The Authors report their personal experience in this type of treatment where good results are due to: 1) combination of a powerful, stable laser source 2) durable side-emission contact fibre 3) laser resector, which also in the absence of epicystostomy maintains a good flow during the operation. However, “laser resection” should still be considered an experimental procedure to be used for randomised protocols or on selected patients (high risk of bleeding, Jehovah's witnesses, carriers of pace-maker, etc.).

SECRETION OF DIHYDROTESTOSTERONE BY HUMAN PROSTATE IN BENIGN PROSTATIC HYPERTROPHY

1974 ◽  
Vol 77 (2) ◽  
pp. 401-407 ◽  
Author(s):  
J. A. Mahoudeau ◽  
A. Delassalle ◽  
H. Bricaire
Keyword(s):  
Plasma Levels ◽  
Benign Prostatic Hypertrophy ◽  
Prostatic Hypertrophy ◽  
Human Prostate ◽  
Control Subjects ◽  
Peripheral Plasma ◽  
Significant Difference ◽  
Before And After ◽  
The Mean ◽  
And Control

ABSTRACT Plasma levels of testosterone (T) and 5α-dihydrotestosterone (DHT) were determined by radioimmunoassay in 29 patients with benign prostatic hypertrophy (BPH) and in 56 control men of various ages. No significant difference was found in T, DHT nor DHT/T ratio between BPH and control subjects of similar age. Plasma DHT was higher in the prostatic than in the peripheral veins in 8/9 patients with BPH during laparotomy, indicating a prostatic secretion of DHT. No difference in the mean T nor the mean DHT was found in peripheral plasma before and after adenomectomy.

Sign in / Sign up

Export Citation Format

Share Document